Clinical Trial Update: Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating lithium for chemotherapy-induced neutropenia in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Neutropenia

Drugs mentioned

• Lithium (Lithium carbonate)

Snippet

Sponsor: Al-Azhar University | Conditions: Neutropenia | Phase 3 | Status: COMPLETED